Alzheimer research forum live discussion: Calcium in AD pathogenesis

Journal of Alzheimer's Disease

Volumn 16, Issue 4, 2009, Pages 909-917

  Atwood, Craig ^a   Bacskai, Brian ^b   Kuchibhotla, Kishore ^b   Bezprozvanny, Ilya ^c   Chakroborty, Shreaya ^d   Fagan, Tom ^e   Foskett, Kevin ^f   Green, Kim ^g   Goussakov, Ivan ^d   Moyer, James ^h   Michno, Kinga ^h   Rybalchenko, Volodymyr ⁱ   Stutzmann, Beth ^j   Villalobos, Carlos ^k  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^d ROSALIND FRANKLIN UNIVERSITY OF MEDICINE AND SCIENCE   (United States)

^e Alzheimer Research Forum   (United States)

^f UNIVERSITY OF PENNSYLVANIA   (United States)

^g UNIVERSITY OF CALIFORNIA   (United States)

^h UNIVERSITY OF TORONTO   (Canada)

ⁱ UNIVERSITY OF NORTH TEXAS   (United States)

^j ROSALIND FRANKLIN UNIVERSITY OF MEDICINE AND SCIENCE   (United States)

^k CSIC   (Spain)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; CALCIUM; CALCIUM ANTAGONIST; CALCIUM CHANNEL; DANTROLENE; DIMEBON; INOSITOL 1,4,5 TRISPHOSPHATE RECEPTOR; MEMANTINE; NIMODIPINE; NONSTEROID ANTIINFLAMMATORY AGENT; PRESENILIN; RYANODINE RECEPTOR;

AGING; ALZHEIMER DISEASE; CALCIUM METABOLISM; CELL CULTURE; DENDRITIC CELL; ENDOPLASMIC RETICULUM; GENE EXPRESSION; HUMAN; LONG TERM DEPRESSION; MENTAL DETERIORATION; NERVE DEGENERATION; NONHUMAN; NOTE; PATHOGENESIS; PRIORITY JOURNAL; ANIMAL; ARTICLE; METABOLISM; PATHOLOGY;

ALZHEIMER DISEASE; ANIMALS; CALCIUM; HUMANS;

EID: 67649700035     PISSN: 13872877     EISSN: None     Source Type: Journal    
DOI: 10.3233/JAD-2009-1026     Document Type: Note

References (19)

1. Bezprozvanny I, Mattson MP (2008) Neuronal calcium mishandling and the pathogenesis of Alzheimer's disease. Trends Neurosci 31, 454-463
2. Lee G, Pollard HB, Arispe N (2002) Annexin 5 and apolipoprotein E2 protect against Alzheimer's amyloid-beta-peptide cytotoxicity by competitive inhibition at a common phosphatidylserine interaction site. Peptides 23, 1249-1263 (Pubitemid 34786704)
3. Zatti G, Burgo A, Giacomello M, Barbiero L, Ghidoni R, Sinigaglia G, Florean C, Bagnoli S, Binetti G, Sorbi S, Pizzo P, Fasolato C (2006) Presenilin mutations linked to familial Alzheimer's disease reduce endoplasmic reticulum and Golgi apparatus calcium levels. Cell Calcium 39, 539-550
4. Kasri NN, Kocks SL, Verbert L, Hébert SS, Callewaert G, Parys JB, Missiaen L, De Smedt H (2006) Up-regulation of inositol 1,4,5-trisphosphate receptor type 1 is responsible for a decreased endoplasmic-reticulum Ca2+ content in presenilin double knock-out cells. Cell Calcium 40, 41-51. (Pubitemid 43785820)
5. Tu H, Nelson O, Bezprozvanny A, Wang Z, Lee SF, Hao YH, Serneels L, De Strooper B, Yu G, Bezprozvanny I (2006) Presenilins form ER Ca2+ leak channels, a function disrupted by familial Alzheimer's disease-linked mutations. Cell 126, 981-993 (Pubitemid 44310781)
6. Stutzmann GE, Smith I, Caccamo A, Oddo S, Laferla FM, Parker I (2006) Enhanced ryanodine receptor recruitment contributes to Ca2+ disruptions in young, adult, and aged Alzheimer's disease mice. J Neurosci 26, 5180-5189 (Pubitemid 44315299)
7. Bowen RL, Atwood CS (2004) Living and dying for sex. A theory of aging based on the modulation of cell cycle signaling by reproductive hormones. Gerontology 50, 265-290
8. Thibault O, Gant JC, Landfield PW (2007) Expansion of the calcium hypothesis of brain aging and Alzheimer's disease: minding the store. Aging Cell 6, 307-317 (Pubitemid 46785136)
9. Tolar M, Marques MA, Harmony JA, Crutcher KA (1997) Neurotoxicity of the 22 kDa thrombin-cleavage fragment of apolipoprotein E and related synthetic peptides is receptor-mediated. J Neurosci 17, 5678-5686 (Pubitemid 27310484)
10. Moulder KL, Narita M, Chang LK, Bu G, Johnson EM (1999) Analysis of a novel mechanism of neuronal toxicity produced by an apolipoprotein E-derived peptide. J Neurochem 72, 1069-1080 (Pubitemid 29085021)
11. Tolar M, Keller JN, Chan S, Mattson MP, Marques MA, Crutcher KA (1999) Truncated apolipoprotein E (ApoE) causes increased intracellular calcium and may mediate ApoE neurotoxicity. J Neurosci 19, 7100-7110 (Pubitemid 29380135)
12. Veinbergs I, Everson A, Sagara Y, Masliah E (2002) Neurotoxic effects of apolipoprotein E4 are mediated via dysregulation of calcium homeostasis. J Neurosci Res 67, 379-387 (Pubitemid 34137145)
13. Qiu Z, Gruol DL (2003) Interleukin-6, beta-amyloid peptide and NMDA interactions in rat cortical neurons. J Neuroimmunol 139, 51-57 (Pubitemid 36694390)
14. Huang X, Atwood CS, Moir RD, Hartshorn MA, Tanzi RE, Bush AI (2004) Trace metal contamination initiates the apparent auto-aggregation, amyloidosis, and oligomerization of Alzheimer's Abeta peptides. J Biol Inorg Chem 9, 954-960 (Pubitemid 40109902)
15. Roychaudhuri R, Yang M, Hoshi MM, Teplow DB (2008) Amyloid beta-protein assembly and Alzheimer's disease. J Biol Chem. Oct 9.
16. Frackowiak J, Potempska A, LeVine H, Haske T, Dickson D, Mazur-Kolecka B (2005) Extracellular deposits of A beta produced in cultures of Alzheimer disease brain vascular smooth muscle cells. J Neuropathol Exp Neurol 64, 82-90. (Pubitemid 40189482)
17. Liu T, Perry G, Chan HW, Verdile G, Martins RN, Smith MA, Atwood CS (2004) Amyloid-beta-induced toxicity of primary neurons is dependent upon differentiation-associated increases in tau and cyclin-dependent kinase 5 expression. J Neurochem 88, 554-563 (Pubitemid 38140200)
18. Wu J, Li Q, Bezprozvanny I (2008) Evaluation of Dimebon in cellular model of Huntington's disease. Mol Neurodegener 15.
19. Doody RS, Gavrilova SI, Sano M, Thomas RG, Aisen PS, Bachurin SO, Seely L, Hung D, dimebon investigators (2008) Effect of dimebon on cognition, activities of daily living, behaviour, and global function in patients with mild-to-moderate Alzheimer's disease: a randomised, double-blind, placebo-controlled study. Lancet 372, 207-215